Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Rev Mal Respir ; 28(10): 1207-15, 2011 Dec.
Artigo em Francês | MEDLINE | ID: mdl-22152930

RESUMO

Computed tomography is important for the diagnosis and follow-up of chronic diffuse interstitial lung diseases. Image quality has improved from each generation of scanner to the next and this continues to allow a better characterization of extent of pathology, or even the nature of the pathological process (potentially reversible inflammatory lesions compared to fibrotic lesions). The diagnostic imaging approach has evolved at the same time as technological developments. We initially thought in terms of the predominant lesions (nodular, alveolar consolidation, ground-glass opacity), and then moved to reasoning based on patterns, which are a combination of several elementary lesions (typically for the diagnosis of idiopathic pulmonary fibrosis). Nowadays, studies are focused on building models characterizing a specific disease and which combine several distinct patterns (typically for ground-glass opacity analysis). CT also allows a quantification of the extent of lung disease, which is linked to the prognosis of the disease and helps to monitor its progression. This quantification is usually based on visual criteria, the principles of which are summarized here. The development of automated quantification software could in the near future, be a support for the radiologist.


Assuntos
Doenças Pulmonares Intersticiais/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Diagnóstico Diferencial , Progressão da Doença , Fibrose , Seguimentos , Humanos , Processamento de Imagem Assistida por Computador , Pulmão/diagnóstico por imagem , Pulmão/patologia , Pneumopatias/complicações , Pneumopatias/diagnóstico , Doenças Pulmonares Intersticiais/etiologia , Doenças Pulmonares Intersticiais/patologia , Medidas de Volume Pulmonar/métodos , Linfonodos/diagnóstico por imagem , Linfonodos/patologia , Prognóstico , Tomografia Computadorizada por Raios X/métodos
2.
Redox Rep ; 6(5): 319-25, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11778850

RESUMO

We previously reported that irradiation of titanium dioxide (TiO2) in ethanol generates both singlet oxygen (1O2) and superoxide anion (O2*-) as measured by EPR spectroscopy. The present study describes the production of reactive oxygen species upon irradiation of TiO2 in aqueous suspension as determined by EPR spectroscopy using 2,2,6,6-tetramethyl-4-piperidone (4-oxo-TMP) and 5,5-dimethyl-pyrroline-N-oxide (DMPO). Photoproduction of 1O2 by suspended TiO2, detected as 2,2,6,6-tetramethyl-4-piperidone-N-oxyl (4-oxo-TEMPO), was measured in water and deuterium oxide (D2O) in the presence or absence of sodium azide (NaN3) and under air or argon atmospheres. Production of a DMPO-OH adduct was examined in 4-oxo-TMP containing medium in the presence or absence of dimethyl sulfoxide (DMSO). The signal for the DMPO spin adduct of superoxide anion was not observed in aqueous conditions. Kinetic analysis revealed that 1O2 was produced at the surface of irradiated TiO2 in aqueous suspension as was observed in ethanol. Kinetic analysis revealed that the formation of DMPO-OH adduct reflects oxidation of DMPO by 1O2 rather than the trapping of the hydroxyl radical produced by the reaction of photo-exited TiO2 and water. The production of large amounts of 1O2 by TiO2 in aqueous suspension as compared to those in ethanol and possible formation of hydroxyl radical in aqueous suspension but not in alcohol, suggest that irradiation of TiO2 in aqueous environments is biologically more important than that in non-aqueous media.


Assuntos
Fármacos Fotossensibilizantes/efeitos da radiação , Espécies Reativas de Oxigênio/metabolismo , Superóxidos/metabolismo , Titânio/efeitos da radiação , Antioxidantes/metabolismo , Óxidos N-Cíclicos/metabolismo , Espectroscopia de Ressonância de Spin Eletrônica , Peróxido de Hidrogênio/metabolismo , Fármacos Fotossensibilizantes/metabolismo , Piperidonas/metabolismo , Marcadores de Spin , Detecção de Spin , Titânio/metabolismo , Raios Ultravioleta
3.
Clin Exp Pharmacol Physiol ; 27(9): 709-14, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10972538

RESUMO

1. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, has been reported to decrease the oxidizability of plasma lipids in hyperlipidaemic subjects. In order to elucidate one of the mechanisms of this in vivo, we investigated the effects of fluvastatin and pravastatin on the decreased turnovers of reduced glutathione (GSH) and ascorbic acid (AA) in Watanabe heritable hyperlipidaemic (WHHL) rabbits. 2. These drugs (30 mg/kg per day) equally decreased plasma levels of lipids after a 4 week treatment period. However, only fluvastatin significantly decreased thiobarbituric acid-reactive substances, which were increased in the plasma of WHHL. 3. Although these drugs did not affect the steady state levels of total glutathione and low molecular weight thiols in the liver and kidney, fluvastatin markedly normalized the rate of GSH turnover in these tissues, as determined by using L-buthionine-(S,R)-sulphoximine, a specific inhibitor of GSH synthesis. 4. Fluvastatin also increased the clearance of AA from the circulation in WHHL. 5. These results suggest that, in addition to its hypolipidaemic action, fluvastatin has the potential to improve the turnover of anti-oxidants, which is closely related to the amelioration of the redox status in the body.


Assuntos
Anticolesterolemiantes/farmacologia , Ácido Ascórbico/metabolismo , Ácidos Graxos Monoinsaturados/farmacologia , Glutationa/metabolismo , Inibidores de Hidroximetilglutaril-CoA Redutases/farmacologia , Hiperlipidemias/metabolismo , Indóis/farmacologia , Animais , Antimetabólitos/farmacologia , Ácido Ascórbico/sangue , Butionina Sulfoximina/farmacologia , Colesterol/sangue , Fluvastatina , Glutationa/sangue , Glutationa Peroxidase/metabolismo , Glutationa Transferase/metabolismo , Hiperlipidemias/sangue , Hiperlipidemias/tratamento farmacológico , Rim/efeitos dos fármacos , Rim/metabolismo , Fígado/efeitos dos fármacos , Fígado/enzimologia , Fígado/metabolismo , Masculino , Oxirredução/efeitos dos fármacos , Fosfolipídeos/sangue , Pravastatina/farmacologia , Coelhos , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Triglicerídeos/sangue
4.
Free Radic Biol Med ; 27(3-4): 294-300, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10468201

RESUMO

Although photoexcited TiO2 has been known to initiate various chemical reactions, such as the generation of reactive oxygen species, precise mechanism and chemical nature of the generated species remain to be elucidated. The present work demonstrates the generation of singlet oxygen by irradiated TiO2 in ethanol as measured by ESR spectroscopy using 2,2,6,6-tetramethyl-4-piperidone (4-oxo-TMP) as a 1O2-sensitive trapping agent. Under identical conditions, the superoxide ion was also detected by spin trapping agent 5,5-dimethyl-pyrroline-N-oxide (DMPO). Kinetic analysis in the presence of both 4-oxo-TMP and DMPO revealed that singlet oxygen is produced directly at the irradiated TiO2 surface but not by a successive reaction involving superoxide anion. The basis for this view is the fact that DMPO added in the mixture increased the signals responsible for 4-oxo-2,2,6,6-tetramethyl-1-piperidinyloxy (4-oxo-TEMPO), a reaction product of 4-oxo-TMP and 1O2. The detailed mechanism for the generation of 1O2 and superoxide ion by irradiated TiO2 and reactions between these species and DMPO are discussed.


Assuntos
Fármacos Fotossensibilizantes/efeitos da radiação , Espécies Reativas de Oxigênio/metabolismo , Superóxidos/metabolismo , Titânio/efeitos da radiação , Raios Ultravioleta , Espectroscopia de Ressonância de Spin Eletrônica , Fármacos Fotossensibilizantes/metabolismo , Piperidonas/metabolismo , Detecção de Spin , Titânio/metabolismo , Triacetonamina-N-Oxil/análogos & derivados , Triacetonamina-N-Oxil/metabolismo
5.
Arch Biochem Biophys ; 363(2): 213-8, 1999 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-10068442

RESUMO

To know the metabolism of low-molecular-weight S-nitrosothiols (RS-NO) in the circulation, we analyzed the stability and depressor effects of S-nitrosoglutathione (GS-NO) and the l- and d-forms of S-nitrosocysteine (Cys-NO). Although half-lives of these RS-NO in fresh plasma were longer than 50 min, their depressor effects disappeared within 5 min after intravenous administration of these compounds. Acivicin (AT-125), an inhibitor of gamma-glutamyltransferase (gamma-GTP), prolonged the depressor effect of GS-NO but not of Cys-NO. The depressor effect of GS-NO disappeared in AT-125-treated rats within 10 min after administration, which is still shorter than its half-life in vitro. Although S-conjugates of l-cysteine, but not of d-cysteine, rapidly enter into cells via an active transport system and disappear from the circulation, both forms of Cys-NO exhibited similar activity to decrease blood pressure to that of NO. Thus, NO might be rapidly released from Cys-NO in the circulation and shortly exhibited its depressor action. These observations suggested that the circulating GS-NO is rapidly decomposed by gamma-GTP to form Cys-NO and that the release of NO from both GS-NO and Cys-NO is enhanced significantly in the circulation.


Assuntos
Cisteína/análogos & derivados , Glutationa/análogos & derivados , Compostos Nitrosos/metabolismo , S-Nitrosotióis , Acetilcisteína/análogos & derivados , Acetilcisteína/sangue , Acetilcisteína/metabolismo , Acetilcisteína/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Cisteína/administração & dosagem , Cisteína/sangue , Cisteína/metabolismo , Cisteína/farmacologia , Inibidores Enzimáticos/farmacologia , Glutationa/administração & dosagem , Glutationa/sangue , Glutationa/metabolismo , Glutationa/farmacologia , Isoxazóis/farmacologia , Masculino , Óxido Nítrico/administração & dosagem , Óxido Nítrico/metabolismo , Óxido Nítrico/farmacologia , Compostos Nitrosos/administração & dosagem , Compostos Nitrosos/sangue , Compostos Nitrosos/farmacologia , Ratos , Ratos Wistar , S-Nitrosoglutationa , gama-Glutamiltransferase/antagonistas & inibidores , gama-Glutamiltransferase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA